Yimin Cui
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Biological Psychiatry top 5%
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 23
- Atrial Fibrillation Management and Outcomes 20
- Surgery 55
- Lipoproteins and Cardiovascular Health 17
- Co-authors
- Qian Xiang (90 shared papers)Ying Zhou (51 shared papers)Xia Zhao (48 shared papers)Hanxu Zhang (26 shared papers)Xiaocong Pang (11 shared papers)Yanlun Gu (11 shared papers)He Xu (8 shared papers)Zhiwei Qiu (5 shared papers)
- Journals
- Frontiers in Pharmacology (9 papers)Clinical Therapeutics (8 papers)British Journal of Clinical Pharmacology (7 papers)Current Pharmaceutical Design (5 papers)Frontiers in Immunology (5 papers)
- Partner nations
- ChinaUnited StatesEstonia
In The Last Decade
Yimin Cui
253 papers receiving 4.4k citations
Yimin Cui's Hit Papers
Peers
Comparison fields: 5 of 166
- Internal Medicine 154
- Biological Psychiatry 102
- Geriatrics and Gerontology 150
- Cancer Research 412
- Pharmacology 229
Countries citing papers authored by Yimin Cui
This map shows the geographic impact of Yimin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimin Cui more than expected).
Fields of papers citing papers by Yimin Cui
This network shows the impact of papers produced by Yimin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimin Cui. The network helps show where Yimin Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Yimin Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting integrin pathways: mechanisms and advances in therapy Hit paper breakdown → | 2023 | 610 |
| 2 | 2019 | 145 | |
| 3 | 2006 | 140 | |
| 4 | 2006 | 105 | |
| 5 | 2004 | 83 | |
| 6 | 2019 | 82 | |
| 7 | 2017 | 81 | |
| 8 | Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis Hit paper breakdown → | 2024 | 78 |
| 9 | 2005 | 75 | |
| 10 | 2013 | 72 | |
| 11 | 2020 | 67 | |
| 12 | 2009 | 64 | |
| 13 | 2012 | 59 | |
| 14 | 2019 | 58 | |
| 15 | 2021 | 53 | |
| 16 | 2015 | 49 | |
| 17 | 2020 | 47 | |
| 18 | 2020 | 46 | |
| 19 | 2005 | 45 | |
| 20 | 2018 | 42 |
About Yimin Cui
Yimin Cui is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology, Oncology and Hematology, having authored 266 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (23 papers), Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (20 papers), Lipoproteins and Cardiovascular Health (17 papers), Pharmacogenetics and Drug Metabolism (16 papers), Diabetes Treatment and Management (13 papers), Folate and B Vitamins Research (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). The work is most often cited by research in Internal Medicine (154 citations), Biological Psychiatry (102 citations), Geriatrics and Gerontology (150 citations), Cancer Research (412 citations) and Pharmacology (229 citations). Yimin Cui has collaborated with scholars based in China, United States and Estonia. Frequent co-authors include Qian Xiang, Ying Zhou, Xia Zhao, Hanxu Zhang, Xiaocong Pang, Yanlun Gu, He Xu, Zhiwei Qiu, Xiaocong Pang and Ran Xie. Their work appears in journals such as Frontiers in Pharmacology, Clinical Therapeutics, British Journal of Clinical Pharmacology, Current Pharmaceutical Design and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.